INDECOPI working to defend the Peruvian biological resources works together with the Ministry of Foreign Affairs of Peru to defend abroad, cases of biopiracy. Up to today there are 9 pending cases of biopiracy in favour of Peru, i.e. the state has intervened in other IPO offices to stop the granting of a patent which is based on Peruvian biological products.
This year alone, there have been 7 oppositions (the other 2 were dealt with last year) filed against applications against the following patent applications:
Philippines IPO
• A composition for enhancing male libido (PH 2015000586U), referring to a pharmaceutical composition comprising the combination of extracts of aphrodisiac plants selected from Maca (Lepidium meyenii), Huanarpo Macho I (Jatropha macrantha), Huanarpo Macho II (Corynaea crassa) And Chuchuhuasi (Maytenus laevis). Said composition is used in the treatment of sexual dysfunction in men.
• A formulation for female breast and buttocks enhancement (PH 2015000587U), referring to a pharmaceutical composition comprising the combination of extracts of Aguaje (Mauritia flexuosa) and Maca (Lepidium meyenii), to enhance and favour female attributes.
People's Republic of China IPO
• (CN 201610791732), referring to a composition comprising extracts of maca (Lepidium meyenii) and cistanche, to be used as an energizer.
• (CN 201610618712), which relates to a composition comprising an extract of the shells of Plukenetia volubilis, sacha inchi, for the treatment of hypertension and a method of extraction.
• "Anti-inflammatory and anti-oxidant composition and related method of use" (CN 104066434), on the use of tara as anti-oxidant and anti-inflammatory.
Taiwan, opposition to the patent application
• "Anti-inflammatory and anti-oxidant composition and related method of use" (TW 201340975) - related to the use of tara as anti-inflammatory and anti-oxidant.
•
Hong Kong IPO
• Anti-inflammatory and anti-oxidant composition and related method of use "(HK 1199197) - related to the use of tara as anti-inflammatory and anti-oxidant.
The National Commission reports that since its creation in May 2004, it has identified 30 cases of biopiracy in the world related to Peruvian biological resources in the patent system: 18 have been resolved favourably for Peru; 9 pending; 1 registration which is suspended; and 2 which were granted (but before the creation of the Commission).
0 Response to "Biopiracy: the role of the national IP"
Post a Comment